# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement an...
3 software stocks, Intrusion, Katapult, & PaySign, surge in momentum rankings, signaling strong price performance in the se...
Lake Street analyst Jacob Stephan maintains PaySign (NASDAQ:PAYS) with a Buy and raises the price target from $9 to $10.
PaySign (NASDAQ:PAYS) sees Q3 sales of $19.500 million-$20.500 million vs $18.926 million analyst estimate.
PaySign (NASDAQ:PAYS) is looking for FY2025 GAAP EPS of $0.10-$0.12 vs $0.12 analyst estimate. Raises FY2025 sales outlook from...
PaySign (NASDAQ:PAYS) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.04 by 42...